Clinical Study on Treatment of Hepatocyte Growth - Promoting Factor for Infant Hepatitis Syndrome / 实用儿科临床杂志
Journal of Applied Clinical Pediatrics
; (24)1992.
Article
in Zh
| WPRIM
| ID: wpr-638447
Responsible library:
WPRO
ABSTRACT
Objective To explore the clinical efficacy and side effect of hepatocyte growth - promoting factor in treatment of infant hepatitis syndrome. Methods Sixty one cases of infant hepatitis syndrome were chased as the treatment group who hospitalized in our hospital from March 2002 to Feb 2003,and 54 cases of infant hepatitis syndrome as control group who hospitalized during March 2001 to Feb 2002. The treatment group were administrated with hepatocyte growth - promoting factor for 2 weeks. We obser-ved the recovery of patient's liver function (TBIL.ALT, AST) and the side effect of hepatocyte growth- promoting factor after two weeks of the treatment. Results After the treatment,TBIL and ALT decreased significantly in the treatment group of infant hepatitis syndrome. The treatment group was superior to the control group (P
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of Applied Clinical Pediatrics
Year:
1992
Type:
Article